Dear Editor: Dulaglutide is a glucagon-like peptide (GLP-1) receptor agonist, which stimulates insulin release via activation of GLP-1 receptors on pancreatic beta cells. Here, we report the first case of morbilliform drug eruption to dulaglutide. Case presentation. An 84-year-old male patient with a medical history of Type 2 diabetes mellitus, hyperlipidemia, hypertension, and back pain
Dear Editor: Topical field-directed treatment is well-established for actinic keratosis (AK) lesions, which are considered premalignant sun-related skin lesions. The most commonly used local treatments for AK lesions are diclofenac, 5-fluroouracil, imiquimod, and ingenol mebutate.1 Ingenol mebutate, the latest introduction to the dermatologist’s therapeutic quiver for actinic keratosis, is an effective and well-tolerated option, with
Dear Editor: Tooth discoloration associated with dental hygiene products is commonplace in the field of dentistry; in dermatology, tetracycline is a known cause of tooth discoloration in children.1 We present a case of a 40-year-old Caucasian woman who developed sudden-onset tooth discoloration during her rosacea treatment, which included oral doxycycline. Intrinsic and extrinsic causes of
Dear Editor: An African American man in his 50s presented with a one-year history of a pruritic rash on his anterior shins. His past medical history was significant for a recent diagnosis of diabetes. A physical examination revealed scattered, atrophic, pink/purple papules and plaques with reticular pigment on the bilateral anterior lower legs (Figure 1).
Dear Editor: Public awareness of diseases has been shown to increased when celebrities publicly disclose their own.1–3 Hugh Jackman’s public disclosure of his basal cell carcinoma diagnoses via social media is an example in dermatology.4 Here, we evaluated current trends on vitiligo, with emphasis on two celebrities with the condition: the late “King of Pop,”